Newsroom
News from UCLB
LifeArc® launches Technology Transfer Fellowships
London, UK, December 17th, 2018. LifeArc, a leading UK medical research charity, is delighted to launch a new Technology Transfer ...
SmartTarget® technology pinpoints biopsies to detect prostate cancer
Medical software developed at UCL that overlays tumour information from MRI scans onto ultrasound images can help guide surgeons conducting ...
UCL Spinouts Feature in Industrial Strategy Life Sciences Sector Deal Two
The government has published the second Life Sciences Sector Deal, which outlines public and private sector investments into the sector ...
Freeline Presents Data on AAV-based Gene Therapy for Haemophilia B at the 60th ASH Annual Meeting
A single infusion of FLT180a resulted in sustained mean Factor IX activity of 45%, with no toxicity or adverse effects, ...
UCL Technology Fund invests in IGEM Therapeutics
UCLTF has invested in a series A round for immuno-oncology company IGEM Therapeutics. The £5million funding round also included investment ...
UCL Spinout Hazy Features in Forbes
AI spinout Hazy, featured in a recent Forbes list selecting the 15 Machine Learning Companies to Watch in Europe. Hazy ...
UCL Spin-out Engitix Closes £5m Financing to Progress Liver Disease & Pancreatic Cancer Drug Discovery Platform & Pipeline
Engitix Ltd, a company pioneering the development of both tissue-specific and disease-specific human extracellular matrix (ECM) for accelerating and improving ...
UCL Spinout SmartTarget Appoints New CEO Bruce Lynn
SmartTarget Ltd, a spinout of UCL (University College London) that has developed a CE-approved device for precision prostate biopsy and ...
UCLTF’s Simon Goldman and David Grimm make the Top 25 of the GUV Powerlist 2018
Simon Goldman and David Grimm, who are responsible for managing investments for the UCL Technology Fund, the fund co-managed by ...
£438 million investment for UCL gene therapy spinouts
UCL spinout Orchard Therapeutics, a biotechnology company dedicated to transforming the lives of patients with rare disorders through innovative gene ...
UCLB spinout Orchard Therapeutics announces closing of $225 million Initial Public Offering
UCLB spinout Orchard Therapeutics, a biopharmaceutical company dedicated to transforming the lives of patients with serious and life-threatening rare diseases ...
Orchard Therapeutics announces pricing of its initial public offering
UCLB spinout Orchard Therapeutics has announced the pricing of its initial public offering in the United States of 14,285,715 American ...
UCLB spinout Endomag wins the prestigious British Business Innovation Award from the Institute of Physics
UCLB spinout Endomag, the surgical guidance company, has won a prestigious British Business Innovation Award from the Institute of Physics ...
Global University Venturing Interviews UCLTF’s David Grimm
UCLTF investment manager David Grimm recently spoke to Global University Venturing editor Thierry Heles to explain more about how the ...
Announcing Cengiz Tarhan’s retirement from UCLB
Having spent 30 years at UCL, 25 of those at UCLB, Cengiz Tarhan announces his intention to retire, stepping down ...
